Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Harm Reduction Journal|March 15, 2024
Acceptance and feasibility of a low-threshold and substitution services-based periodical monitoring system for blood-borne and sexually transmitted infections among people who inject drugs in Germany: a mixed-methods analysisAmrei Krings, Gyde Steffen, Ruth Zimmermann, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|December 16, 2020
[How to assess the elimination of viral hepatitis B, C, and D in Germany? Outcomes of an interdisciplinary workshop]Ruth Zimmermann, Wiebe Külper-Schiek, Gyde Steffen, et al.
Histochemistry and Cell Biology|November 12, 2010
LINE-1 retrotransposition events affect endothelial proliferation and migrationFerya Banaz-Yaşar, Gyde Steffen, Jessica Hauschild, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|January 14, 2022
[Epidemiology of viral hepatitis A to E in Germany]Sandra Dudareva, Mirko Faber, Ruth Zimmermann, et al.
BMC Infectious Diseases|August 15, 2021
Hepatitis B vaccination coverage in Germany: systematic reviewGyde Steffen, Ida Sperle, Thomas Harder, et al.
Harm Reduction Journal|December 20, 2024
Progress and challenges in the elimination of hepatitis C among people who inject drugs in Germany: results of a pilot study for a national monitoring system, 10 years after the first data collectionGyde Steffen, Amrei Krings, Sarah Guttmann, et al.
Plos One|March 10, 2020
The epidemiology of Hepatitis B, C and D in Germany: A scoping reviewGyde Steffen, Ida Sperle, Siv Aina Leendertz, et al.
The Pediatric Infectious Disease Journal|December 15, 2018
Overestimation of an Outbreak of Enterobacter cloacae in a Neonatal Intensive Care Unit in Germany, 2015Gyde Steffen, Michael Pietsch, Martin Kaase, et al.
Antimicrobial Resistance and Infection Control|February 5, 2022
Geographical differences of carbapenem non-susceptible Enterobacterales and Acinetobacter spp. in Germany from 2017 to 2019Anja von Laer, Tim Eckmanns, Benedikt Zacher, et al.
BMC Infectious Diseases|February 9, 2020
STI in times of PrEP: high prevalence of chlamydia, gonorrhea, and mycoplasma at different anatomic sites in men who have sex with men in GermanyKlaus Jansen, Gyde Steffen, Anja Potthoff, et al.
Pageof 2